CSI Market
Sign In | Register

Immunogen inc (IMGN) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMGN quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Immunogen inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent275.14
Cash & Short-term Investments275.00
Accounts receivable12.60
Unbilled Receivables, Current RE1.53
Deferred Finance Costs, Current, Net DE0.00
Other Current Assets3.85
Prepaid Expense And Other Assets Current11.01
Total Current Assets304.12
Equipment/Property/Plant Net4.38
Tax Assets, Noncurrent0.00
Deferred Finance Costs, Noncurrent, Net DE10.00
Other Assets, Noncurrent30.00
Contract With Customer Asset Gross Current0.00
Non Cash Royalty Receivable3.85
Operating Lease Right Of Use Asset10.23
Total Assets348.94
Liabilities
Accounts Payable, Current AC45.35
Employee-related Liabilities, Current AC11.11
Convertible Debt, Current LO0.00
Other Liabilities, Current65.39
Total Current Liabilities121.86
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt0.00
Incentive from Lessor DE0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent71.25
Liability Related To Sale Of Future Royalties Current8.66
Operating Lease Liability Current4.10
Contract With Customer Liability Current13.86
Liability Related To Sale Of Future Royalties Noncurrent23.45
Total Liabilities193.11
Stockholders' Equity
Common Stock Value2.26
Additional Paid In Capital Common Stock1,847.64
Retained Earnings / Accumulated Deficit-1,694.07
Other Equity0.00
Common Stockholder's Equity155.83
Total Stockholder's Equity155.83
Liabilities & Stockholder's Equity348.94
4 historic quarters locked

Sign in to unlock the full Immunogen inc balance sheet history.

Sign In Create Free Account

About Immunogen Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-23-017411

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License